Cost Effectiveness of Exemestane versus Tamoxifen in Post-Menopausal Women with Early Breast Cancer in Germany

BACKGROUND: Medical studies have shown that switching to exemestane after 2-3 years of adjuvant treatment with tamoxifen is effective when looking at overall survival. No cost effectiveness study of exemestane has been conducted in the German health care context. PATIENTS AND METHODS: To assess the...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Main Authors: Braun, Sebastian, Mittendorf, Thomas, Menschik, Thomas, Greiner, Wolfgang, von Schulenburg, Johann-Matthias
Format: Artigo
Sprog:Inglês
Udgivet: S. Karger GmbH 2009
Fag:
Original Article · Originalarbeit
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC2942002/
https://ncbi.nlm.nih.gov/pubmed/20877674
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1159/000255840
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker